Senya Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $555K

  • Investors
  • 8

Senya Therapeutics General Information

Description

Developer of biologics intended for unmet clinical needs in nephrology, oncology, ophthalmology, and other indications. The company utilizes antibody-based products against a protein target that promotes vascular destabilization and uninhibited blood-vessel formation in pathology, enabling medical staff & doctors to normalize and improve the vascularization of solid tumors with penetration and improved efficacy for small molecules, biologics, and cell therapies.

Contact Information

Website
www.senyatx.com
Formerly Known As
PanAngium Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 90 Tottenham Court Road
  • London W1T 4TJ
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 90 Tottenham Court Road
  • London W1T 4TJ
  • England, United Kingdom

Senya Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Senya Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 04-Feb-2026 $555K Completed Startup
4. Seed Round 01-Jun-2024 Completed Pre-Clinical Trials
3. Grant 04-Jan-2024 Completed Pre-Clinical Trials
2. Seed Round 03-May-2019 $716K $716K Completed Startup
1. University Spin-Out 08-Feb-2019 Completed Startup
To view Senya Therapeutics’s complete valuation and funding history, request access »

Senya Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Preferred
Seed Preferred
Seed Preferred 173,333 $0.000001 $1.22 $1.22 1x $1.22 3.58%
B Ordinary 550,000 $0.000001 $1.35 $1.35 1x $1.35 11.37%
To view Senya Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Senya Therapeutics Patents

Senya Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202502132-D0 Therapeutic Inactive 13-Feb-2025

Senya Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Senya Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
AlbionVC Venture Capital Minority
Cambridge Technology Capital Fund Mezzanine Minority
Cancer Research Technology Venture Capital Minority
NG Bio (UK) Venture Capital Minority
UCL Technology Fund Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Senya Therapeutics FAQs

  • When was Senya Therapeutics founded?

    Senya Therapeutics was founded in 2019.

  • Where is Senya Therapeutics headquartered?

    Senya Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Senya Therapeutics?

    Senya Therapeutics has 2 total employees.

  • What industry is Senya Therapeutics in?

    Senya Therapeutics’s primary industry is Drug Discovery.

  • Is Senya Therapeutics a private or public company?

    Senya Therapeutics is a Private company.

  • What is the current valuation of Senya Therapeutics?

    The current valuation of Senya Therapeutics is .

  • What is Senya Therapeutics’s current revenue?

    The current revenue for Senya Therapeutics is .

  • How much funding has Senya Therapeutics raised over time?

    Senya Therapeutics has raised $3.55M.

  • Who are Senya Therapeutics’s investors?

    AlbionVC, Cambridge Technology Capital Fund, Cancer Research Technology, NG Bio (UK), and UCL Technology Fund are 5 of 8 investors who have invested in Senya Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process